Sarcio

Minneapolis, United States

Sarcio uses regenerative cartilage cell therapy to treat patients suffering from the effects of Osteoarthritis.

$608K raised

Jul 2023

Seed

Top Investors

Groove Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sarcio raised?

Sarcio has raised $608K in total funding. The most recent round was Seed. The last funding was announced in July 2023.

Who are Sarcio's investors?

Sarcio's investors include Groove Capital.

Where is Sarcio headquartered?

Sarcio is headquartered in Minneapolis, United States.

What does Sarcio do?

Sarcio uses regenerative cartilage cell therapy to treat patients suffering from the effects of Osteoarthritis.

What stage is Sarcio at?

Sarcio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 17, 2023.

MLA

"Sarcio — Funding & Investors." VCBacked, July 17, 2023, https://www.vcbacked.co/company/sarcio. Accessed June 3, 2026.

APA

VCBacked. (2023). Sarcio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/sarcio

Wikipedia (cite web)

{{cite web |title=Sarcio — Funding & Investors |url=https://www.vcbacked.co/company/sarcio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 17, 2023.